| 67782-3 | Surgical operation date | |
| 29306-8 | Surgery procedure | |
| 80398-1 | Unique ID Current sample | |
| 84893-7 | Info local ext+meta for staging Tumor | |
| 81169-5 | Residual tumor Postop Imp Cancer | |
| 21939-4 | Surg margins cancer invol | |
| 22634-0 | Path report.gross Spec | |
| 81168-7 | Adj org or tiss involved Ca spec | |
| 33725-3 | Tumor site | |
| 33728-7 | Size.max.dim Tumor | |
| 81178-6 | Block description and site Spec | |
| 86467-8 | Rpt comment | |
| 33731-1 | Histology type Ca spec | |
| 33732-9 | Histology grade Ca spec | |
| 98250-4 | Neuroendocrine tumor | |
| 98390-8 | Epithelial comp carcinosarcoma % | |
| 98391-6 | Sarcoma comp carcinosarcoma % | |
| 98392-4 | Sarcoma pattern carcinosarcoma | |
| 98251-2 | Stage EC spec FIGO | |
| 98252-0 | Histo grade EC spec Ql | |
| 98253-8 | Myometrial invasion EC spec Ql | |
| 98254-6 | Depth myometrial invasion EC spec | |
| 98255-3 | Myometrial invasion/Myometrial LenFr | |
| 98256-1 | Extent myometrial invasion EC spec Ql | |
| 98257-9 | MELF invasion pattern EC spec Ql | |
| 98258-7 | Myoinvasive tumor from serosa EC spec | |
| 59544-7 | Lymph-vascular invasion Ca spec | |
| 33725-3 | Tumor site | |
| 98259-5 | Vessels involved LVI Ca spec | |
| 98260-3 | LVI extent Ca spec Ql | |
| 98261-1 | Stromal invasion EC spec Ql | |
| 98262-9 | Tumor dist cerv resect margins EC | |
| 98263-7 | Vaginal involvement EC spec Ql | |
| 98264-5 | Omental involvement EC spec Ql | |
| 98265-2 | Peritoneal biopsy involvement EC spec Ql | |
| 98266-0 | Uterine serosa involvmnt EC spec Ql | |
| 98267-8 | Parametrial involvement EC spec Ql | |
| 98268-6 | Adnexal involvement EC spec Ql | |
| 98269-4 | Adnexal site EC spec | |
| 98270-2 | Background endometrium EC spec | |
| 98271-0 | Hormonal phase EC spec | |
| 55600-1 | Cyto Prt | |
| 81168-7 | Adj org or tiss involved Ca spec | |
| 21892-5 | LN involved Cancer | |
| 98272-8 | L Pelvic LN examined Spec | |
| 98273-6 | L Pelvic LN positive Spec | |
| 98274-4 | R Pelvic LN examined Spec | |
| 98275-1 | R Pelvic LN positive Spec | |
| 98276-9 | Para-aortic LN examined Spec | |
| 98277-7 | Para-aortic LN positive Spec | |
| 98278-5 | Path protocol sentinel nodes | |
| 85351-5 | LN metastasis.max dim Ca spec Micro | |
| 85350-7 | Extranodal ext of ca Ca spec Ql Micro | |
| 84890-3 | Dist mets conf by histology Ca spec Ql | |
| 22635-7 | Path report.microscopic Spec Other Stn | |
| 50398-7 | Narrative diagnostic report-Imp | |
| 55229-9 | Immune stain study | |
| 98279-3 | DNA MMR Ca spec ImStn | |
| 98280-1 | Optimal tissue block Ca spec | |
| 21902-2 | Stg grp.pathology Cancer | |
| 34574-4 | Path report.final Dx Spec | |
| 77202-0 | Laboratory comment Report | |
| 98281-9 | Reporting protocol used | |
| 98249-6 | Cancer Path Pnl EC spec | |